BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18086603)

  • 1. Dermatitis herpetiformis in a patient receiving infliximab for ankylosing spondylitis.
    Marakli SS; Uzun S; Ozbek S; Tuncer I
    Eur J Dermatol; 2008; 18(1):88-9. PubMed ID: 18086603
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis.
    Capkin E; Karkucak M; Yayli S; Aydin Çapkin A; Tosun M
    J Clin Rheumatol; 2011 Aug; 17(5):293-4. PubMed ID: 21808187
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitiligo improvement in a patient with ankylosing spondylitis treated with infliximab.
    Simón JA; Burgos-Vargas R
    Dermatology; 2008; 216(3):234-5. PubMed ID: 18182816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab.
    Mueller MC; Fleischmann E; Grunke M; Schewe S; Bogner JR; Löscher T
    Am J Trop Med Hyg; 2009 Jul; 81(1):52-4. PubMed ID: 19556566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab.
    Paschou S; Voulgari PV; Vrabie IG; Saougou IG; Drosos AA
    J Rheumatol; 2009 Feb; 36(2):351-4. PubMed ID: 19040305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary arrest after severe anaphylactic reaction to second infusion of infliximab in a patient with ankylosing spondylitis.
    Miki H; Okamoto A; Ishigaki K; Sasaki O; Sumitomo S; Fujio K; Yamamoto K
    J Rheumatol; 2011 Jun; 38(6):1220. PubMed ID: 21632692
    [No Abstract]   [Full Text] [Related]  

  • 7. Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation.
    de Vries MK; Wolbink GJ; Stapel SO; de Groot ER; Dijkmans BA; Aarden LA; van der Horst-Bruinsma IE
    Ann Rheum Dis; 2007 Jan; 66(1):133-4. PubMed ID: 17178760
    [No Abstract]   [Full Text] [Related]  

  • 8. Uveitis and tumour necrosis factor blockade in ankylosing spondylitis.
    Coates LC; McGonagle DG; Bennett AN; Emery P; Marzo-Ortega H
    Ann Rheum Dis; 2008 May; 67(5):729-30. PubMed ID: 18408116
    [No Abstract]   [Full Text] [Related]  

  • 9. Sézary syndrome in a patient receiving infliximab for ankylosing spondylitis.
    Dauendorffer JN; Rivet J; Allard A; Bachelez H
    Br J Dermatol; 2007 Apr; 156(4):742-3. PubMed ID: 17263820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis induced by infliximab in a Saudi patient with ankylosing spondylitis.
    Alabed IB; Qushmaq KA; Khan MA
    Saudi Med J; 2010 Sep; 31(9):1054-6. PubMed ID: 20844821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab.
    Fabre C; Dereure O
    Dermatology; 2008; 216(2):185-6. PubMed ID: 18216487
    [No Abstract]   [Full Text] [Related]  

  • 12. Asthenoazoospermia in patients receiving anti-tumour necrosis factor {alpha} agents.
    Montagna GL; Malesci D; Buono R; Valentini G
    Ann Rheum Dis; 2005 Nov; 64(11):1667. PubMed ID: 16227427
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous granulomas during infliximab therapy for spondyloarthropathy.
    Dubosc AE; Perroud AM; Bagot M; Farenq V; Chevalier X; Maitre B; Claudepierre P
    J Rheumatol; 2008 Jun; 35(6):1222-3. PubMed ID: 18412298
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythema nodosum associated with infliximab therapy.
    Rosen T; Martinelli P
    Dermatol Online J; 2008 Apr; 14(4):3. PubMed ID: 18627725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis?
    Gaspersic N; Sersa I; Jevtic V; Tomsic M; Praprotnik S
    Ann Rheum Dis; 2008 Sep; 67(9):1354. PubMed ID: 18697784
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythema multiforme with tumour necrosis factor inhibitors: a class effect?
    Kain T; MacGregor D; Buchanan RR; de Jager JP; Schachna L
    Ann Rheum Dis; 2008 Jun; 67(6):899-900. PubMed ID: 18474663
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-TNF-associated palmoplantar pustulosis.
    Pyrpasopoulou A; Chatzimichailidou S; Simoulidou E; Aslanidis S
    J Clin Rheumatol; 2010 Apr; 16(3):138-9. PubMed ID: 20216329
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab-induced acne: report of two cases.
    Bassi E; Poli F; Charachon A; Claudepierre P; Revuz J
    Br J Dermatol; 2007 Feb; 156(2):402-3. PubMed ID: 17223901
    [No Abstract]   [Full Text] [Related]  

  • 19. Abdominal pain in a patient with ankylosing spondylitis under treatment with infliximab.
    Cooper J; Flückiger B; Traichl B; Diener PA; Otto P; von Kempis J
    J Clin Rheumatol; 2009 Aug; 15(5):244-6. PubMed ID: 19590442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab].
    Gutierrez M; Becciolini A; Bertolazzi C; Di Geso L; Tardella M; Ariani A; Filippucci E; Grassi W
    Reumatismo; 2010; 62(3):221-4. PubMed ID: 21052570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.